[go: up one dir, main page]

DK3016970T3 - O-mannosyltransferase-defekte filamentøse svampeceller og fremgangsmåder til anvendelse deraf - Google Patents

O-mannosyltransferase-defekte filamentøse svampeceller og fremgangsmåder til anvendelse deraf Download PDF

Info

Publication number
DK3016970T3
DK3016970T3 DK14734515.1T DK14734515T DK3016970T3 DK 3016970 T3 DK3016970 T3 DK 3016970T3 DK 14734515 T DK14734515 T DK 14734515T DK 3016970 T3 DK3016970 T3 DK 3016970T3
Authority
DK
Denmark
Prior art keywords
mannosyltransferase
defected
filaments
methods
spot cells
Prior art date
Application number
DK14734515.1T
Other languages
English (en)
Inventor
Jari Natunen
Jukka Hiltunen
Anne Huuskonen
Markku Saloheimo
Christian Ostermeier
Benjamin Patrick Sommer
Ramon Wahl
Original Assignee
Glykos Finland Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48740957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3016970(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glykos Finland Oy filed Critical Glykos Finland Oy
Application granted granted Critical
Publication of DK3016970T3 publication Critical patent/DK3016970T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01109—Dolichyl-phosphate-mannose-protein mannosyltransferase (2.4.1.109)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
DK14734515.1T 2013-07-04 2014-07-03 O-mannosyltransferase-defekte filamentøse svampeceller og fremgangsmåder til anvendelse deraf DK3016970T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13175141 2013-07-04
PCT/EP2014/064248 WO2015001049A1 (en) 2013-07-04 2014-07-03 O-mannosyltransferase deficient filamentous fungal cells and methods of use thereof

Publications (1)

Publication Number Publication Date
DK3016970T3 true DK3016970T3 (da) 2019-06-24

Family

ID=48740957

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14734515.1T DK3016970T3 (da) 2013-07-04 2014-07-03 O-mannosyltransferase-defekte filamentøse svampeceller og fremgangsmåder til anvendelse deraf

Country Status (15)

Country Link
US (4) US20160376570A1 (da)
EP (1) EP3016970B1 (da)
KR (1) KR102111078B1 (da)
CN (1) CN105492457A (da)
BR (1) BR112015032695A2 (da)
CA (1) CA2916594C (da)
DK (1) DK3016970T3 (da)
ES (1) ES2739280T3 (da)
HR (1) HRP20191069T1 (da)
MX (1) MX364532B (da)
PL (1) PL3016970T3 (da)
RU (1) RU2016103373A (da)
SG (1) SG11201510814YA (da)
SI (1) SI3016970T1 (da)
WO (1) WO2015001049A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3172333B1 (en) 2014-07-21 2020-05-13 Glykos Finland Oy Production of glycoproteins with mammalian-like n-glycans in filamentous fungi
CA3113661A1 (en) * 2018-09-20 2020-03-26 Perfect Day, Inc. Methods and compositions for producing homokaryotic filamentous fungal cells
CA3121271A1 (en) * 2018-11-28 2020-06-04 Novozymes A/S Modified filamentous fungal host cells
CN110885810B (zh) * 2019-12-16 2021-03-23 华中农业大学 一种利用真核发酵制备得到的抑菌蛋白酶CmYC1及其应用
CN115976033B (zh) * 2022-12-14 2024-05-17 西南大学 瓜实蝇tssk1和tssk3基因及其应用
KR20250004526A (ko) * 2023-06-29 2025-01-08 씨제이제일제당 (주) 아스파르트산 프로테아제 변이체
CN119931997B (zh) * 2025-04-09 2025-07-25 安琪酵母股份有限公司 天冬氨酸蛋白酶突变体及其应用

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4743546A (en) 1985-02-13 1988-05-10 Biotechnica International, Inc. Controlled gene excision
GB2276169A (en) 1990-07-05 1994-09-21 Celltech Ltd Antibodies specific for carcinoembryonic antigen
DE4244915C2 (de) 1992-08-14 1998-12-03 Widmar Prof Dr Tanner DNA-Moleküle codierend Proteine, die an der O-Glykosylierung von Proteinen beteiligt sind
WO1998011203A1 (en) 1996-09-13 1998-03-19 Novo Nordisk Biotech, Inc. Cells having dna insertion mutations which produce altered amounts of a polypeptide
DE19754622A1 (de) 1997-12-09 1999-06-10 Antje Von Dr Schaewen Pflanzliche GntI-Sequenzen und Verwendung derselben zur Gewinnung von Pflanzen mit verminderter oder fehlender N-Acetylglucosaminyltransferase I (GnTI)-Aktivität
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
GB0021421D0 (en) 2000-08-31 2000-10-18 Oxford Glycosciences Uk Ltd Compounds
RU2003120093A (ru) 2000-12-05 2005-01-27 Дзе Пенн Стейт Рисерч Фаундейшн (Us) Способы и композиции для высокоэффективного получения гетерологичных белков в дрожжах
EP1573017B1 (en) 2002-12-20 2008-07-09 Unilever Plc Preparation of antifreeze protein
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
ZA200605449B (en) 2003-12-03 2007-11-28 Delta Biotechnology Ltd Interleukin-11 fusion proteins
ES2567634T3 (es) 2004-02-09 2016-04-25 Human Genome Sciences, Inc. Proteínas de fusión de albúmina
WO2006036817A2 (en) 2004-09-24 2006-04-06 Microbia, Inc. Fungal variants and uses thereof
DK1941025T3 (da) * 2005-10-17 2011-09-26 Novozymes As Brug af svampemutanter til ekspression af antistoffer
ES2534465T3 (es) 2005-11-15 2015-04-23 Glycofi, Inc. Producción de glucoproteínas con O-glucosilación reducida
KR20090031359A (ko) 2006-05-16 2009-03-25 교와 핫꼬 기린 가부시키가이샤 단백질의 고분비 생산 방법
US8680252B2 (en) 2006-12-10 2014-03-25 Dyadic International (Usa), Inc. Expression and high-throughput screening of complex expressed DNA libraries in filamentous fungi
GB0711424D0 (en) 2007-06-13 2007-07-25 Novozymes Delta Ltd Recombinant transferrin mutants
EP2594583A1 (en) 2007-08-08 2013-05-22 Novozymes Biopharma DK A/S Transferrin variants and conugates
WO2009105357A1 (en) * 2008-02-20 2009-08-27 Glycofi, Inc. Vectors and yeast strains for protein production
US20090253173A1 (en) * 2008-04-08 2009-10-08 Danisco Us Inc., Genencor Division Filamentous fungi with inactivated protease genes for altered protein production
CA2721459A1 (en) 2008-05-20 2009-11-26 Merck Sharp & Dohme Corp. Efficient production of heterologous proteins using mannosyl transferase inhibitors
JP2011530311A (ja) * 2008-08-12 2011-12-22 グライコフィ， インコーポレイテッド タンパク質製造のための改良されたベクターおよび酵母株：Ｃａ２＋ＡＴＰアーゼ過剰発現
WO2010034708A1 (en) 2008-09-23 2010-04-01 Unilever Plc A polynucleotide expression cassette
KR101722961B1 (ko) 2009-02-11 2017-04-04 알부메딕스 에이/에스 알부민 변이체 및 접합체
EP2427488A1 (en) 2009-05-07 2012-03-14 Novozymes Biopharma DK A/S Method of controlling o-linked glycosylation of antibodies
WO2010128143A1 (en) 2009-05-07 2010-11-11 Novozymes Biopharma Dk A/S Method of controlling o-linked glycosylation of antibodies
US8440456B2 (en) 2009-05-22 2013-05-14 Vib, Vzw Nucleic acids of Pichia pastoris and use thereof for recombinant production of proteins
EP2488657B1 (en) 2009-10-16 2016-07-06 Merck Sharp & Dohme Corp. Method for producing proteins in pichia pastoris that lack detectable cross binding activity to antibodies against host cell antigens
US8986974B2 (en) 2009-12-18 2015-03-24 Novozymes, Inc. Methods for producing polypeptidies in protease-deficient mutants of trichoderma
CN103003438B (zh) 2010-02-10 2016-01-20 拜康有限公司 减少蛋白质糖基化的方法和过程及其蛋白质
AU2011220878A1 (en) * 2010-02-24 2012-08-23 Merck Sharp & Dohme Corp. Method for increasing N-glycosylation site occupancy on therapeutic glycoproteins produced in Pichia pastoris
US9187552B2 (en) 2010-05-27 2015-11-17 Merck Sharp & Dohme Corp. Method for preparing antibodies having improved properties
US20120135461A1 (en) 2010-07-30 2012-05-31 William James Cook Production of glycoproteins with reduced o-glycosylation comprising the use of an alpha-1,2-mannosidase
KR20140018851A (ko) 2010-11-24 2014-02-13 노파르티스 인터내셔널 파마슈티칼 리미티드 N-아세틸글루코사미닐트랜스퍼라제 활성을 갖는 융합 효소
JP5885191B2 (ja) 2011-01-04 2016-03-15 国立研究開発法人産業技術総合研究所 糖鎖改変酵母及びそれを用いた糖タンパク質の製造方法
AU2012220890A1 (en) 2011-02-25 2013-08-29 Merck Sharp & Dohme Corp. Yeast strain for the production of proteins with modified O-glycosylation
CN103582650A (zh) 2011-05-25 2014-02-12 默沙东公司 用于制备具有改善性质的含Fc多肽的方法
AR087433A1 (es) 2011-08-08 2014-03-26 Merck Sharp & Dohme Analogos de insulina n-glicosilados
WO2013062886A1 (en) * 2011-10-27 2013-05-02 Merck Sharp & Dohme Corp. Controlling o-glycosylation in lower eukaryotes
EP2773661A4 (en) 2011-10-31 2015-06-17 Merck Sharp & Dohme PROCESS FOR PREPARING ANTIBODIES WITH IMPROVED PROPERTIES
WO2013066765A1 (en) 2011-11-01 2013-05-10 Merck Sharp & Dohme Corp. Mutation of tup1 in glycoengineered yeast
US20140302028A1 (en) 2011-11-18 2014-10-09 Merck Sharp & Dohme Corp. Fc containing polypeptides having increased anti-inflammatory properties and increased fcrn binding
DK2852610T3 (da) 2012-05-23 2018-09-03 Glykos Finland Oy Produktion af fucosylerede glycoproteiner
AU2013335065B2 (en) 2012-10-22 2018-10-25 Merck Sharp & Dohme Llc CRZ1 mutant fungal cells
AU2013363266A1 (en) 2012-12-17 2015-05-07 Merck Sharp & Dohme Corp. pmt2, och1, pmt5 Mutant Cells
WO2014126787A1 (en) 2013-02-13 2014-08-21 Merck Sharp & Dohme Corp. Methods for increasing n-glycan occupancy and reducing production of hybrid n-glycans in pichia pastoris strains lacking alg3 expression
CA2903739A1 (en) 2013-03-06 2014-09-12 Glaxosmithkline Llc Host cells and methods of use
WO2014182684A2 (en) 2013-05-06 2014-11-13 Cell Machines, Inc. Methods and compositions related to large scale production of proteins
EP3004156A1 (en) 2013-06-07 2016-04-13 Novo Nordisk A/S Method for making mature insulin polypeptides
WO2015013116A1 (en) 2013-07-25 2015-01-29 Merck Sharp & Dohme Corp. Method for reducing the extent of o-mannosylation of glycoproteins
US20160215061A1 (en) 2013-10-08 2016-07-28 Merck Sharp & Dohme Corp. Fc CONTAINING POLYPEPTIDES HAVING INCREASED BINDING TO FcGammaRIIB
WO2015073307A2 (en) 2013-11-13 2015-05-21 Merck Sharp & Dohme Corp. Fc CONTAINING POLYPEPTIDES HAVING INCREASED BINDING TO HUMAN DC-SIGN

Also Published As

Publication number Publication date
CN105492457A (zh) 2016-04-13
US20220213451A1 (en) 2022-07-07
CA2916594A1 (en) 2015-01-08
US10724013B2 (en) 2020-07-28
MX364532B (es) 2019-04-29
EP3016970A1 (en) 2016-05-11
RU2016103373A3 (da) 2018-03-26
KR20160030127A (ko) 2016-03-16
RU2016103373A (ru) 2017-08-10
SI3016970T1 (sl) 2019-08-30
KR102111078B1 (ko) 2020-05-18
SG11201510814YA (en) 2016-01-28
US20160376570A1 (en) 2016-12-29
WO2015001049A1 (en) 2015-01-08
HRP20191069T1 (hr) 2019-11-01
CA2916594C (en) 2020-03-10
US20200362319A1 (en) 2020-11-19
PL3016970T3 (pl) 2019-09-30
ES2739280T3 (es) 2020-01-30
EP3016970B1 (en) 2019-05-22
MX2016000128A (es) 2016-03-01
US20200040314A1 (en) 2020-02-06
BR112015032695A2 (pt) 2017-10-24

Similar Documents

Publication Publication Date Title
IL254734B1 (en) Modified t cells and methods of making and using the same
DK3087095T3 (da) FcRn-antagonist og fremgangsmåder til anvendelse
PL3623943T3 (pl) Urządzenie przenośne i sposób ograniczania korzystania z urządzenia przenośnego
HRP20170840T1 (hr) Supstituirani ksantini i metode njihove uporabe
DK3043784T3 (da) Arylethere og anvendelser deraf
DK2844292T3 (da) ST2L-antagonister og fremgangsmåder til anvendelse
IL241224A (en) Electrode array and method of placement
IL244488A0 (en) Inhibitors of erk and methods of use
DK3086807T3 (da) Antistoffer og fremgangsmåder til anvendelse
IL245036B (en) Pesticidal compositions and related methods
DK3079719T3 (da) ANTI-SIGLEC-8-antistoffer og fremgangsmåder til anvendelse deraf
DK3003039T3 (da) Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser
DK2962100T3 (da) Tuberkulosebiomarkører og anvendelser deraf
DK3077467T3 (da) Sikkativsammensætning og anvendelse deraf
DK3082902T3 (da) Kropsbåret injektor og anvendelsesmetode
DK3063144T3 (da) Antiparasitære og pesticid-isoxazolinforbindelser
DK3071248T3 (da) Vævsstilladsmateriale til vævsregenerering og fremgangsmåder til fremstilling
DK2964767T3 (da) Toksingener og fremgangsmåder til anvendelse deraf
DK3030549T3 (da) Pyridazinonforbindelser og anvendelser deraf
DK3029038T3 (da) Tetrazolinonforbindelse og anvendelse deraf
IL243728A0 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
DK3326642T3 (da) Langtidsvirkende koagulationsfaktorer og brugen deraf
DK3022361T4 (da) Rambuk og fremgangsmåde til anvendelse deraf
EP3066193C0 (en) CELL CULTURE PROCESS
DK3016970T3 (da) O-mannosyltransferase-defekte filamentøse svampeceller og fremgangsmåder til anvendelse deraf